All In Biotech

Drug Trial Radar · NCT07857265

Mass Balance Study of [14C]DA-302168S in Healthy Chinese Adult Male Participants

A Clinical Study on the Mass Balance of [14C]DA-302168S in Healthy Adult Male Trial Participants in China

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Nov 20, 2026

Primary completion

Dec 20, 2026

Study completion Dec 20, 2026

Sponsor

Sponsor type
Industry
First posted
Oct 5, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In this study, a single dose of \[14C\] radiolabelled DA-302168S will be administered orally. The main purpose of this study is to find out how much of DA-302168S and its metabolites pass from blood into urine and feces, and characterize the metabolic profile and routes of excretion of oral \[14C\] DA-302168S.

Conditions

  • Healthy Adult Subjects

Interventions

  • [14C] DA-302168SDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total recovery of DA-302168S radioactivity in urine and feces, following oral administration of [14C] DA-302168STime frame: Predose up to Day 8 after administration of [14C]DA-302168S

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.